SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-165451
Filing Date
2010-07-26
Accepted
2010-07-26 06:40:41
Documents
4
Period of Report
2010-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26759
2 PRESS RELEASE dex991.htm EX-99.1 8318
3 GRAPHIC g98179g72q70.jpg GRAPHIC 4733
4 GRAPHIC g98179g76c39.jpg GRAPHIC 3088
  Complete submission text file 0001193125-10-165451.txt   47769
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 10968407
SIC: 2834 Pharmaceutical Preparations